In the light of the findings of hepatotoxicity in products for internal use, containing Chelidonium Majus (Celandine), the IMB have concluded that there is a negative benefit-risk ratio for oral preparation containing this herb. A voluntary withdrawal has been agreed … Continue reading
May 2, 2003